[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"saps\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:saps":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,52],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100653925","nociplastic-pain-in-patients-diagnosed-with-subacromial-pain-syndrome-saps-100653925",false,"NCT07792434","Nociplastic Pain in Patients Diagnosed With Subacromial Pain Syndrome (SAPS)","Prevalence of Nociplastic Pain Phenotype in Patients Diagnosed With Subacromial Pain Syndrome (SAPS) - a Cross-sectional Study","The NAP SAPS","Inclusion Criteria:\n\n1. Diagnosed with SAPS (dm751, dm753, dm754, dm755\n2. Shoulder pain ≥ 3 months\n3. ≥ 3 out of 5 specific shoulder tests\n4. Age 18-70 years\n5. Increased pain during active arm elevation\n6. Pain during active elevation ≥ 3 (VAS)\n\nExclusion Criteria:\n\n1. Severe visual impairment\n2. Epilepsy\n3. Severe cognitive or physical impairment\n4. Language barrier (Danish)","ALL","18 Years","70 Years",{"count":21,"type":22},400,"ESTIMATED","OBSERVATIONAL","The goal of this cross-sectional study is to estimate the prevalence of the nociplastic pain phenotype, according to the IASP clinical criteria, among patients diagnosed with SubAcromial Pain Syndrome (SAPS).\n\nThe main question it aims to answer is: What is the prevalence of the nociplastic pain phenotype in patients diagnosed with SAPS in an outpatient clinic?\n\nPrimary outcome: Proportion of patients with SAPS meeting the IASP criteria for nociplastic pain.",[26,27,28,29,30],"Subacromial Pain Syndrome","Rotator Cuff Related Shoulder Pain","Shoulder Pain","Shoulder Impingement Syndrome","SAPS",[32,30,33,27,34,35,36,37,38],"Shoulder pain","Nociplastic pain","Virtual Reality","musculoskeletal pain","pain phenotype","central sensitivation","Chronic pain","NOT_YET_RECRUITING","2026-10-05",{"date":42,"type":43},"2026-10-06","ACTUAL",{"date":45,"type":22},"2026-10-19",{"date":47,"type":22},"2028-08",{"name":49,"class":50},"Vejle Hospital","OTHER",1,{"id":53,"slug":54,"hasResults":11,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":60,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":62,"conditions":63,"keywords":64,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":74,"leadSponsor":76,"locationsCount":51},"100653909","pain-phenotype-and-response-to-corticosteroid-injection-in-patients-with-subacromial-pain-syndrome-saps-100653909","NCT07792421","Pain Phenotype and Response to Corticosteroid Injection in Patients With Subacromial Pain Syndrome (SAPS)","Association Between Pain Phenotype and Change in Pain Following Routine Corticosteroid Injection in Patients With Subacromial Pain Syndrome - A Prospective Cohort Study.","NAP SAPS CSI","Inclusion Criteria:\n\n1. Diagnosed with SAPS (dm751, dm753, dm754, dm755\n2. Shoulder pain ≥ 3 months\n3. ≥ 3 out of 5 specific shoulder test\n4. Age 18-70 years\n5. Increased pain during active arm elevation\n6. Pain during active elevation ≥ 3 (VAS)\n7. Receving a corticosteroid injection based on routine clinical proctice\n\nExclusion Criteria:\n\n1. Severe visual impairment\n2. Epilepsy\n3. Severe cognitive or physical impairment\n4. Language barrier (Danish)\n5. Receving a corticosteroid injection at a site other than the subacromial bursa (e.g. acromioclavicular joint or intra-articular injection)",{"count":61,"type":22},134,"The goal of this prospective cohort study is to investigate whether pain phenotype is associated with subsequent change in pain intensity after corticosteroid injection given as part of routine care in patients diagnosed with SAPS.\n\nThe main question it aims to answer is:\n\nDoes change in shoulder pain from baseline to 4 weeks after corticosteroid injection differ between patients classified as having a nociplastic pain phenotype and those classified as having a non-nociplastic pain phenotype?",[26,27,28,29,30],[32,30,33,65,66,67,68,38,69],"Rotator cuff related shoulder pain","Musculoskeletal pain","Pain phenotype","Central sensitivation","Corticosteroid injection","2026-10-02",{"date":72,"type":43},"2026-10-07",{"date":45,"type":22},{"date":75,"type":22},"2028-11-30",{"name":49,"class":50}]